• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从黄热病疫苗中学习免疫学:从先天免疫到系统疫苗学

Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.

作者信息

Pulendran Bali

机构信息

Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA.

出版信息

Nat Rev Immunol. 2009 Oct;9(10):741-7. doi: 10.1038/nri2629. Epub 2009 Sep 18.

DOI:10.1038/nri2629
PMID:19763148
Abstract

Despite their great success, we understand little about how effective vaccines stimulate protective immune responses. Two recent developments promise to yield such understanding: the appreciation of the crucial role of the innate immune system in sensing microorganisms and tuning immune responses, and advances in systems biology. Here I review how these developments are yielding insights into the mechanism of action of the yellow fever vaccine, one of the most successful vaccines ever developed, and the broader implications for vaccinology.

摘要

尽管疫苗取得了巨大成功,但我们对有效疫苗如何刺激保护性免疫反应却知之甚少。最近的两项进展有望带来此类认识:一是认识到固有免疫系统在感知微生物和调节免疫反应方面的关键作用,二是系统生物学的进展。在此,我将回顾这些进展如何让我们深入了解黄热病疫苗的作用机制(黄热病疫苗是有史以来最成功的疫苗之一),以及它们对疫苗学更广泛的影响。

相似文献

1
Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.从黄热病疫苗中学习免疫学:从先天免疫到系统疫苗学
Nat Rev Immunol. 2009 Oct;9(10):741-7. doi: 10.1038/nri2629. Epub 2009 Sep 18.
2
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?黄热病疫苗——它是如何起作用的,以及为什么会发生罕见的严重不良事件?
Curr Opin Immunol. 2009 Jun;21(3):308-13. doi: 10.1016/j.coi.2009.05.018. Epub 2009 Jun 10.
3
A qualitatively validated mathematical-computational model of the immune response to the yellow fever vaccine.一种经质量验证的黄热病疫苗免疫反应的数学计算模型。
BMC Immunol. 2018 May 25;19(1):15. doi: 10.1186/s12865-018-0252-1.
4
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.系统生物学方法预测黄热病疫苗在人体中的免疫原性。
Nat Immunol. 2009 Jan;10(1):116-125. doi: 10.1038/ni.1688. Epub 2008 Nov 23.
5
Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses.黄热病 17D 疫苗病毒免疫后小鼠体内 IFN-γ 的早期产生及其与适应性免疫反应的关系。
PLoS One. 2013 Dec 6;8(12):e81953. doi: 10.1371/journal.pone.0081953. eCollection 2013.
6
Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection .III型干扰素介导的信号传导对于控制减毒活黄热病病毒感染至关重要。
mBio. 2017 Aug 15;8(4):e00819-17. doi: 10.1128/mBio.00819-17.
7
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.黄热病病毒疫苗可诱导广泛且多功能的人类记忆性 CD8+ T 细胞应答。
J Immunol. 2009 Dec 15;183(12):7919-30. doi: 10.4049/jimmunol.0803903.
8
Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.利用从黄热病疫苗成功中获得的知识指导登革热疫苗的研发。
Cell Mol Immunol. 2016 Jan;13(1):36-46. doi: 10.1038/cmi.2015.76. Epub 2015 Oct 5.
9
Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response.黄热病毒 17D 诱导的原发性人 T 细胞反应从效应细胞向记忆细胞型成熟的时间动态。
J Immunol. 2013 Mar 1;190(5):2150-8. doi: 10.4049/jimmunol.1202234. Epub 2013 Jan 21.
10
Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D.了解天然免疫在减毒活黄热病疫苗17D作用机制中的作用。
Adv Exp Med Biol. 2007;590:43-53. doi: 10.1007/978-0-387-34814-8_3.

引用本文的文献

1
Mitochondrial hyperactivity and reactive oxygen species drive innate immunity to the yellow fever virus-17D live-attenuated vaccine.线粒体活性过高和活性氧驱动对黄热病病毒17D减毒活疫苗的天然免疫。
PLoS Pathog. 2025 Apr 21;21(4):e1012561. doi: 10.1371/journal.ppat.1012561. eCollection 2025 Apr.
2
Antibiotic-induced gut microbiome perturbation alters the immune responses to the rabies vaccine.抗生素诱导的肠道微生物群扰动会改变对狂犬病疫苗的免疫反应。
Cell Host Microbe. 2025 May 14;33(5):705-718.e5. doi: 10.1016/j.chom.2025.03.015. Epub 2025 Apr 18.
3
Pathogenesis and clinical management of arboviral diseases.

本文引用的文献

1
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION.经体外培养改良的黄热病病毒用于人体免疫。
J Exp Med. 1937 May 31;65(6):787-800. doi: 10.1084/jem.65.6.787.
2
THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS.体外长期培养对黄热病病毒致病性的影响。
J Exp Med. 1937 May 31;65(6):767-86. doi: 10.1084/jem.65.6.767.
3
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?黄热病疫苗——它是如何起作用的,以及为什么会发生罕见的严重不良事件?
虫媒病毒病的发病机制与临床管理
World J Virol. 2025 Mar 25;14(1):100489. doi: 10.5501/wjv.v14.i1.100489.
4
Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models.动力学激活纳米疫苗模拟自然感染的多维免疫调节,在动物模型中对异源病毒具有广泛的保护作用。
Nat Commun. 2025 Mar 25;16(1):2914. doi: 10.1038/s41467-025-58006-y.
5
Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer.黄热病病毒疫苗株17D在小鼠胰腺癌模型中用于瘤内治疗的免疫治疗潜力
Vaccines (Basel). 2025 Jan 6;13(1):40. doi: 10.3390/vaccines13010040.
6
Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans.疫苗诱导的T细胞反应在无中和抗体的情况下控制人类黄病毒属病毒攻击感染。
Nat Microbiol. 2025 Feb;10(2):374-387. doi: 10.1038/s41564-024-01903-7. Epub 2025 Jan 10.
7
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity.编码不同刺突蛋白构象的基于MVA的新型冠状病毒2型候选疫苗可诱导不同的早期转录反应,这可能会影响随后的适应性免疫。
Front Immunol. 2024 Dec 19;15:1500615. doi: 10.3389/fimmu.2024.1500615. eCollection 2024.
8
Yellow Fever: Global Impact, Epidemiology, Pathogenesis, and Integrated Prevention Approaches.黄热病:全球影响、流行病学、发病机制及综合预防方法
Infez Med. 2024 Dec 1;32(4):434-450. doi: 10.53854/liim-3204-3. eCollection 2024.
9
Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine.线粒体活性增强和活性氧驱动对黄热病病毒17D减毒活疫苗的天然免疫。
bioRxiv. 2024 Sep 15:2024.09.04.611167. doi: 10.1101/2024.09.04.611167.
10
The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.T 细胞介导的免疫对预防疫苗可预防疾病的贡献:简介。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2395679. doi: 10.1080/21645515.2024.2395679. Epub 2024 Aug 29.
Curr Opin Immunol. 2009 Jun;21(3):308-13. doi: 10.1016/j.coi.2009.05.018. Epub 2009 Jun 10.
4
Innate immunity to virus infection.对病毒感染的天然免疫
Immunol Rev. 2009 Jan;227(1):75-86. doi: 10.1111/j.1600-065X.2008.00737.x.
5
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.黄热病疫苗可诱导整合的多谱系和多功能免疫反应。
J Exp Med. 2008 Dec 22;205(13):3119-31. doi: 10.1084/jem.20082292. Epub 2008 Dec 1.
6
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.系统生物学方法预测黄热病疫苗在人体中的免疫原性。
Nat Immunol. 2009 Jan;10(1):116-125. doi: 10.1038/ni.1688. Epub 2008 Nov 23.
7
Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.Toll样受体介导的浆细胞样树突状细胞中I型干扰素的诱导需要雷帕霉素敏感的PI(3)K-mTOR-p70S6K信号通路。
Nat Immunol. 2008 Oct;9(10):1157-64. doi: 10.1038/ni.1645. Epub 2008 Aug 31.
8
Functional properties and genomics of glucose transporters.葡萄糖转运蛋白的功能特性和基因组学。
Curr Genomics. 2007 Apr;8(2):113-28. doi: 10.2174/138920207780368187.
9
A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.一种用于血液基因组学研究的模块化分析框架:在系统性红斑狼疮中的应用。
Immunity. 2008 Jul 18;29(1):150-64. doi: 10.1016/j.immuni.2008.05.012.
10
Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes.黄热病疫苗相关内脏型疾病病例,伴有病毒血症持续时间延长、强大的适应性免疫反应以及CCR5和RANTES基因多态性
J Infect Dis. 2008 Aug 15;198(4):500-7. doi: 10.1086/590187.